Drug shows promise for painful sensory neuropathy.
D017326:Clinical Trials, Phase III as Topic; D003930:Diabetic Retinopathy / Q000628:therapy; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D009414:Nerve Growth Factors / Q000627:therapeutic use*; D010523:Peripheral Nervous System Diseases / Q000209:etiology* / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014481:United States
D009414:Nerve Growth Factors; D011994:Recombinant Proteins